WASHINGTON, Aug 20 (Reuters) - Medical monitoring
technology company Masimo ( MASI ) sued U.S. Customs and Border
Protection on Wednesday over a decision by the agency that
allowed Apple ( AAPL ) to import Apple Watches with blood-oxygen
reading technology during a patent dispute between the
companies.
Masimo ( MASI ) said in the lawsuit in Washington, D.C., federal
court that Customs improperly determined that Apple ( AAPL ) can import
watches with pulse oximetry technology, reversing its
own decision from last year without notifying Masimo ( MASI ).
Masimo ( MASI ) told the court that it learned of the agency's August
1 decision only after Apple ( AAPL ) announced it would reintroduce
blood-oxygen reading to its watches last week.
Spokespeople for Apple ( AAPL ) and Customs did not immediately respond
to requests for comment. A Masimo ( MASI ) spokesperson declined to
comment.
Irvine, California-based Masimo ( MASI ) has accused Apple ( AAPL ) of hiring
away its employees and stealing its pulse oximetry technology to
use in its Apple Watches. Masimo ( MASI ) has separately sued Apple ( AAPL ) for
patent infringement and trade secret theft in ongoing federal
court cases.
Masimo ( MASI ) convinced the U.S. International Trade Commission to
block imports of Apple's ( AAPL ) Series 9 and Ultra 2 smartwatches in
2023 based on a determination that Apple's ( AAPL ) technology for
reading blood oxygen levels infringed Masimo's ( MASI ) patents.
Apple ( AAPL ) has continued to sell Customs-approved redesigned
watches without pulse oximetry since the ITC's decision.
Apple ( AAPL ) said on Aug. 14 that it would reintroduce its
smartwatches' blood-oxygen reading capabilities with approval
from Customs. Masimo ( MASI ) said the agency's decision to approve the
watches without input from Masimo ( MASI ) or any "meaningful
justification" deprived the company of its rights.
"CBP's function is to enforce ITC exclusion orders, not to
create loopholes that render them ineffective," Masimo ( MASI ) said.
Masimo ( MASI ) asked the Washington court to halt the agency's
ruling and continue to block Apple ( AAPL ) from selling watches with the
blood-oxygen feature.